Floatz logo

Ifosfamide

Angioimmunoblastic T-Cell Lymphoma

Shandong Provincial HospitalPhase 4 / ApprovedDormant
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
95/ 100

Competitive context

55 Active assets in the Angioimmunoblastic T-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Ou Bai, MD/PHD
Phase 2BB
Fludarabine
National Cancer Institute (NCI)
Phase 2BB
Romidepsin
The Lymphoma Academic Research Organisation
Phase 3BB
ETOPOSIDE
Eric Jacobsen, MD
Phase 4BB
Azacitidine
National Cancer Institute (NCI)
Phase 4BB

View all 50 →

Same molecule, other indications

Ifosfamide is also rated in:

primary mediastinal large B-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →